1
|
Jianpraphat N, Supsavhad W, Ngernmeesri P, Siripattarapravat K, Soontararak S, Akrimajirachoote N, Phaochoosak N, Jermnak U. A New Benzo[6,7]oxepino[3,2-b] Pyridine Derivative Induces Apoptosis in Canine Mammary Cancer Cell Lines. Animals (Basel) 2024; 14:386. [PMID: 38338029 PMCID: PMC10854894 DOI: 10.3390/ani14030386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2023] [Revised: 01/20/2024] [Accepted: 01/23/2024] [Indexed: 02/12/2024] Open
Abstract
CMC is the most frequently diagnosed cancer and one of the leading causes of death in non-spayed female dogs. Exploring novel therapeutic agents is necessary to increase the survival rate of dogs with CMC. MPOBA is a BZOP derivative that has a significant anticancer effect in a human cell line. The main goal of this study was to investigate the anticancer properties of MPOBA against two CMC cell lines (REM134 and CMGT071020) using a 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, a wound healing assay, a transwell migration assay, an Annexin V-FITC apoptosis assay with a flow cytometry analysis, a mRNA expression analysis using quantitative real-time PCR (qRT-PCR), and an immunohistochemistry (IHC). According to the accumulated studies, MPOBA caused significant concentration- and time-dependent reductions in cell proliferation and cell migration and induced apoptosis in both CMC cell lines. In gene expression analysis, nine canine genes, including TP53, BCL-2, BAX, epidermal growth factor receptor (EGFR), snail transcription factor (SNAIL), snail-related zinc-finger transcription factor (SLUG), TWIST, E-cadherin, and N-cadherin, were investigated. The mRNA expression results revealed that MPOBA induced upregulation of TP53 and overexpression of the pro-apoptotic gene BAX, together with an inhibition of BCL-2. Moreover, MPOBA also suppressed the mRNA expression levels of SNAIL, EGFR, and N-cadherin and induced upregulation of E-cadherin, crucial genes related to the epithelial-to-mesenchymal transition (EMT). However, there was no significant difference in the IHC results of the expression patterns of vimentin (VT) and cytokeratin (CK) between MPOBA-treated and control CMC cells. In conclusion, the results of the present study suggested that MPOBA exhibited significant anticancer activity by inducing apoptosis in both CMCs via upregulation of TP53 and BAX and downregulation of BCL-2 relative mRNA expression. MPOBA may prove to be a potential candidate drug to be further investigated as a therapeutic agent for CMC.
Collapse
Affiliation(s)
- Natamon Jianpraphat
- Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand; (N.J.); (N.P.)
| | - Wachiraphan Supsavhad
- Department of Pathology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand; (W.S.); (K.S.)
| | - Paiboon Ngernmeesri
- Department of Chemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand;
| | - Kannika Siripattarapravat
- Department of Pathology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand; (W.S.); (K.S.)
| | - Sirikul Soontararak
- Department of Companion Animal Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand;
| | | | - Napasorn Phaochoosak
- Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand; (N.J.); (N.P.)
| | - Usuma Jermnak
- Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand; (N.J.); (N.P.)
| |
Collapse
|
2
|
Jermnak U, Ngernmeesri P, Yurayart C, Poapolathep A, Udomkusonsri P, Poapolathep S, Phaochoosak N. A New Benzaldehyde Derivative Exhibits Antiaflatoxigenic Activity against Aspergillus flavus. J Fungi (Basel) 2023; 9:1103. [PMID: 37998908 PMCID: PMC10672374 DOI: 10.3390/jof9111103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Revised: 11/03/2023] [Accepted: 11/10/2023] [Indexed: 11/25/2023] Open
Abstract
Aflatoxin B1 (AFB1) is the most potent naturally occurring carcinogen for humans and animals produced by the common fungus Aspergillus flavus (A. flavus). Aflatoxin (AF) contamination in commodities is a global concern related to the safety of food and feed, and it also impacts the agricultural economy. In this study, we investigated the AFB1-inhibiting activity of a new benzaldehyde derivative, 2-[(2-methylpyridin-3-yl)oxy]benzaldehyde (MPOBA), on A. flavus. It was found that MPOBA inhibited the production of AFB1 by A. flavus, with an IC50 value of 0.55 mM. Moreover, the inhibition of conidiation was also observed at the same concentration. The addition of MPOBA resulted in decreased transcript levels of the aflR gene, which encodes a key regulatory protein for the biosynthesis of AF, and also decreased transcript levels of the global regulator genes veA and laeA. These results suggested that MPOBA has an effect on the regulatory mechanism of the development and differentiation of conidia, leading to the inhibition of AFB1 production. In addition, the cytotoxicity study showed that MPOBA had a very low cytotoxic effect on the Madin-Darby canine kidney (MDCK) cell line. Therefore, MPOBA may be a potential compound for developing practically effective agents to control AF contamination.
Collapse
Affiliation(s)
- Usuma Jermnak
- Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand; (A.P.); (P.U.); (S.P.); (N.P.)
| | - Paiboon Ngernmeesri
- Department of Chemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand;
| | - Chompoonek Yurayart
- Department of Veterinary Microbiology and Immunology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand;
| | - Amnart Poapolathep
- Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand; (A.P.); (P.U.); (S.P.); (N.P.)
| | - Pareeya Udomkusonsri
- Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand; (A.P.); (P.U.); (S.P.); (N.P.)
| | - Saranya Poapolathep
- Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand; (A.P.); (P.U.); (S.P.); (N.P.)
| | - Napasorn Phaochoosak
- Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand; (A.P.); (P.U.); (S.P.); (N.P.)
| |
Collapse
|
3
|
De S, Kumar S K A, Shah SK, Kazi S, Sarkar N, Banerjee S, Dey S. Pyridine: the scaffolds with significant clinical diversity. RSC Adv 2022; 12:15385-15406. [PMID: 35693235 PMCID: PMC9121228 DOI: 10.1039/d2ra01571d] [Citation(s) in RCA: 46] [Impact Index Per Article: 23.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2022] [Accepted: 04/27/2022] [Indexed: 12/20/2022] Open
Abstract
The nitrogen-bearing heterocycle pyridine in its several analogous forms occupies an important position as a precious source of clinically useful agents in the field of medicinal chemistry research. This privileged scaffold has been consistently incorporated in a diverse range of drug candidates approved by the FDA (Food and Drug Administration). This moiety has attracted increasing attention from several disease states owing to its ease of parallelization and testing potential pertaining to the chemical space. In the next few years, a larger share of novel pyridine-based drug candidates is expected. This review unifies the current advances in novel pyridine-based molecular frameworks and their unique clinical relevance as reported over the last two decades. It highlights an inclination to the use of pyridine-based molecules in drug crafting and the subsequent emergence of several potent and eligible candidates against a range of diversified diseases. The nitrogen-bearing heterocycle pyridine in its several analogous forms occupies an important position as a precious source of clinically useful agents in the field of medicinal chemistry research.![]()
Collapse
Affiliation(s)
- Sourav De
- Department of Pharmaceutical Technology, School of Medical Science, Adamas University, Kolkata-700126, West Bengal, India
| | - Ashok Kumar S K
- Department of Chemistry, School of Advanced Sciences, VIT, Vellore-632014, India
| | - Suraj Kumar Shah
- Department of Pharmaceutical Technology, School of Medical Science, Adamas University, Kolkata-700126, West Bengal, India
| | - Sabnaz Kazi
- Department of Pharmaceutical Technology, School of Medical Science, Adamas University, Kolkata-700126, West Bengal, India
| | - Nandan Sarkar
- Department of Pharmaceutical Technology, School of Medical Science, Adamas University, Kolkata-700126, West Bengal, India
| | - Subhasis Banerjee
- Department of Pharmaceutical Chemistry, Gupta College of Technological Sciences, Asansol-713301, West Bengal, India
| | - Sanjay Dey
- Department of Pharmaceutical Technology, School of Medical Science, Adamas University, Kolkata-700126, West Bengal, India
| |
Collapse
|
4
|
Zhang X, Miao X, Jiang H, Ge F, Sun J, Zhang R, Ouyang Q, Fan W, Zhu Y, Sun Y. Iodine‐Promoted Synthesis of Dipyrazolo/Diuracil‐Fused Pyridines and
o
‐Amino Diheteroaryl ketones via Oxidative Domino Annulation of 2/4‐Methylazaarenes. Adv Synth Catal 2021. [DOI: 10.1002/adsc.202100839] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- Xin‐Ke Zhang
- School of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University Shandong Yantai 264005 People's Republic of China
| | - Xiao‐Yu Miao
- School of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University Shandong Yantai 264005 People's Republic of China
| | - Hui‐Ru Jiang
- School of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University Shandong Yantai 264005 People's Republic of China
| | - Fei Ge
- School of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University Shandong Yantai 264005 People's Republic of China
| | - Jia‐Chen Sun
- School of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University Shandong Yantai 264005 People's Republic of China
| | - Rui‐Ying Zhang
- School of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University Shandong Yantai 264005 People's Republic of China
| | - Qin Ouyang
- School of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University Shandong Yantai 264005 People's Republic of China
| | - Wei‐Yu Fan
- School of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University Shandong Yantai 264005 People's Republic of China
| | - Yan‐Ping Zhu
- School of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University Shandong Yantai 264005 People's Republic of China
| | - Yuan‐Yuan Sun
- School of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University Shandong Yantai 264005 People's Republic of China
| |
Collapse
|
5
|
Taweesak P, Thongaram P, Kraikruan P, Thanetchaiyakup A, Chuanopparat N, Hsieh HP, Uang BJ, Ngernmeesri P. One-Pot Synthesis of Dibenzo[ b, f]oxepines and Total Synthesis of Bauhinoxepin C. J Org Chem 2021; 86:1955-1963. [PMID: 33400878 DOI: 10.1021/acs.joc.0c02452] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
In this work, we report a novel and simple one-pot synthesis of substituted dibenzo[b,f]oxepines under transition-metal-free conditions. This cascade process involves nucleophilic aromatic substitution followed by Knoevanagel condensation, as evidenced by the isolated reaction intermediates. We have also achieved the synthesis of anticancer bauhinoxepin C in 7 steps with 5.1% overall yield using this synthetic approach.
Collapse
Affiliation(s)
- Pondpavee Taweesak
- Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand
| | - Phanida Thongaram
- Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand
| | - Panitan Kraikruan
- Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand
| | - Adisak Thanetchaiyakup
- Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand
| | - Nutthawat Chuanopparat
- Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand
| | - Hsing-Pang Hsieh
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, 35053, Taiwan.,Department of Chemistry, National Tsing Hua University, Hsinchu, 30013, Taiwan
| | - Biing-Jiun Uang
- Department of Chemistry, National Tsing Hua University, Hsinchu, 30013, Taiwan
| | - Paiboon Ngernmeesri
- Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand
| |
Collapse
|